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Abstract 
Antibodies against he common active site of cholecystokinin (CCK) and gastrin stain three endocrine celltypes in the gut: G-cells (that synthesize 
gastrin) I-cells (that synthesize CCK), and TG-cells (whose product is unknown). In order to examine whether TG-cells either process progastrin 
or proCCK in a specific manner, or express a novel gastrin-CCK related hormone, we studied the distal porcine ileum, which have far more TG- 
than G- and I-cells. Ileal CCK and gastrin mRNA corresponded to those of the antroduodenal mucosa. Gel, ion-exchange and reversed-phase 
chromatography monitored with sequence-specific immunoassays showed that the ileal mucosa on average contain 0.3 and 7.6 pmoYg progastrin 
and proCCK, respectively; 1.1 and 13.5 pmol/g glycine-extended intermediates; and 1.1 and 24.8 pmol/g of bioactive carboxyamidated gastrin and 
CCK, respectively. Gastrin was present only as non-sulfated gastrin-34, whereas CCK occurred in forms similar to those of the proximal intestine. 
Although ileal progastrin processing is tissue specific, the amounts of gastrin and CCK are too small to explain the TG-cells. Moreover, since the 
ileal extracts were without traces of other peptides having the C-terminus common to gastrin and CCK, the results suggest hat TG-cells produce 
a peptide, which is only weakly related to gastrin and CCK. 
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1. Introduction 
Gas&in and cholecystokinin (CCK) have the same bi- 
oactive C-terminus, Trp-Met-Asp-Phe-NH,. The relative 
affinity to gastrin and CCK receptors is determined by 
the structure of the N-terminal extensions of this 
C-terminus. The gastrin gene encodes an 80 and the 
CCK gene a 94 amino acid prohormone. Progastrin ma- 
tures to gastrin-71, -34, -17, -14, and -6 [l]. Correspond- 
ingly, proCCK is processed to CCK-83, -58, -39, -33, -22, 
-8, and -5 [2]. 
G-cells [4]. It is therefore suited for the examination of 
the TG-cell hypothesis. Using sequence-specific mmu- 
noassays [8,9], we have now examined the expression of 
CCK and gastrin, as well as the possible occurrence of 
a related new hormone in the distal porcine ileum. In this 
study we consider three classes of preprohormone prod- 
ucts: prohormones defined as products extended beyond 
the glycine residue at the C-terminus; glycine-extended 
intermediates; and cl-amidated gastrins and CCKs in 
which the C-terminal phenylalanine is amidated using 
glycine as donor. 
In the gut gastrin is synthesized in antroduodenal 
G-cells, whereas CCK is synthesized in small intestinal 
I-cells and few neurons [3-51. In addition the gut con- 
tains TG (‘tetragastrin’)-cells, which also stain with anti- 
bodies against the common C-terminus [4-71. TG-cells, 
however, do not stain with antibodies for mid- and NH,- 
terminal epitopes in gastrin or CCK peptides [4]. Moreo- 
ver, TG-cells are ultrastructurally different from G- and 
I-cells [4,6]. Accordingly, TG-cells may express either a 
new gas&in-CCK related hormone, or they process 
progastrin or proCCK in a unique manner by which only 
the C-terminal epitope is exposed [4]. 
2. Materials and methods 
2.1. Peptide extraction 
The distal ileum contains many TG-, few I-, and no 
Ileal mucosa (0.5 m from the caecum) was removed from adult pigs 
and immediately placed in liquid nitrogen. The frozen tissue was cut in 
pieces of a few milligrams, boiled in water (10 ml/g tissue) for 20 min, 
homogenized and centrifuged at 10,000 x g for 30 min at 4’C. The 
supernatant was decanted (the neutral extract) and the pellet was redis- 
solved in ice-cold acetic acid (10 ml/g) and left at room temperature for 
20 min and centrifuged as above (the acidic extract). In order to concen- 
trate the peptides further, 100 ml of neutral extract in 0.2% trifluoroace- 
tic acid was applied on a Sep-Pak cartridge (Waters Ass, MA, USA), 
washed with 10 ml H,O, 10 ml 10% CH,CN, 10 ml 50% CH&N and 
10 ml 80% CH,CN all in 0.2% trifluoracetic acid. The extract was then 
dried in a vacuum centrifuge and resuspended in 10 ml H,O. 
2.2. Enzymatic treatment 
*Corresponding author. Fax: (45) 35 45 46 40. In order to measure the gastrin and cholecystokinin precursors ex- 
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tended beyond glycine in the amidation site (-Gly-Arg-Arg-), the ex- 
tracts were incubated with TPCK trypsin (LS 0003741), Worthington, 
USA) and carboxypeptidase B (103 233, Boehringer Mannheim, Ger- 
many) [9]. Selected extracts were also incubated with arylsulfatase (2- 
4OOpg Sigma type VIII from Abalone gut in 0.2 M sodium acetate, pH 
5.0, 2 h, 37°C) in order to determine the degree of 0-sulfation. 
2.3. Radioimmunoassays 
The following library of antisera was used: Ab. 2609 is directed 
against the common C-terminus of gastrin and CCK. Ab. 2609 binds 
both hormones irrespective of the degree of sulfation [8]. Ab. 2604 and 
Ab. 2605 are specific for gas&in peptides. While Ab. 2604 measures 
sulfated and non-sulfated gastrins equally, Ab. 2605 react less than 5% 
with sulfated gastrins [ 10,111. Ab. 2605 is consequently used together 
with Ab. 2604 to assess the degree of sulfation. Ab. 1295 (a gift from 
J.H. Walsh, UCLA) is directed against the N-terminal sequence of 
gastrin-17. Thus, the antiserum will bind peptides with an epitope 
similar to the N-terminus of porcine gastrin-17 [12]. Ab. 3208 and Ab. 
5284 are directed against the glycine-extended C-terminus of gastrin. 
Ab. 3208 measures both glycine-extended gastrins and CCKs, whereas 
Ab. 5284 recognizes only non-sulfated glycine-extended gas&ins [9]. 
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Ab. G-160 is specific for sulfated and a-amidated CCK-peptides. Con- 
sequently, it recognizes neither non-sulfated CCK nor gastrins [13]. Ab. 
1564 is directed against sequence 74-79 of porcine proCCK. Conse- 
quently, it recognizes porcine CCK-58, CCK-39, and CCK-33 [14] as 
well as other fragments of proCCK containing sequence 7479. 
2.4. Chromatography 
Extracts were applied to 10 x 1000 mm columns of Sephadex G-50 
superfine (Pharmacia, Sweden) and eluted with 0.02 M Verona1 buffer 
(pH 8.4) at a rate of 4 ml/h. Fractions of 1.3 ml were assayed. The 
columns were calibrated with [‘251]albumin (void volume) and ‘*NaCl 
(total volume) as well as synthetic CCK and gastrin peptides. In order 
to determine the sulfation of CCK peptides, anion-exchange chroma- 
tography was performed using a 10 x 150 mm DE-32 cellulose column 
(Whatman, UK) using a gradient from 0.05 M to 0.5 M NH,HCO,. The 
flow rate was 30 ml/h. Fractions of 2.5 ml were assayed. In order to 
determine the sulfation of gastrin peptides, anion exchange chromatog- 
raphy was carried out on 10 x 150 mm AE-41 cellulose (Whatman, UK) 
columns using a discontinuous gradient from 0.05 (6 h) to 0.2 M 
NH,HCO, (pH 8.3 (300 ml)) [ll]. The flow rate was 33 ml/h. Fractions 
of 2.8 ml were assayed. The identity of the peptides was further ensured 
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Fig. 1. Left panel: gel chromatography of the neutral ileal extracts monitored with antibodies that recognize the C-terminus of gastrin. Five ml ileal 
neutral extract was freeze-dried, redissolved in 1 ml H20, applied to a Sephadex G-50 superfine column (10 x 1000 mm) and eluted at 4°C with 0.02 M 
Verona1 buffer (pH 8.4) at a rate of 4 ml/h. Upper panel, Ab. 2604, which measures ulfated and non-sulfated gastrins equally; Middle panel, Ab. 
2605, which measures ulfated gastrins with low potency; Lower panel, Ab. 5284 directed against non-sulfated glycine-extended gastrins. Upper right 
panel: anion-exchange chromatography of ileal extracts. Of this extract 100 ml extract was subjected to a Sep-Pak C-18 and eluted with 10 ml 50% 
CH,CN in 0.2% trifluoracetic acid, and redissolved to 10 ml with H,O, applied to an AE-41 cellulose column (10 x 150 mm) and eluted at 20°C with 
NH4HC09 in a discontinous gradient as shown in the figure (- - - -). Fraction of 2.8 ml were collected at a rate of 33 ml/h. The elution was monitored 
using Ab. 2604. Lower right panel: neutral extract was purified on a Sep-Pak C-18 Column. Reverse-phase HPLC of ileal neutral extract. 1.2 ml 
of this was applied to a Vydac C, silica column (250 mm), which was eluted with the indicated gradient of CH$H with 10 mM NH&H,COOH 
(solvent B) at 50°C and a flow of 1 .O ml/min (- - ~ -). Fractions of 0.5 ml were assayed with the gastrin specific antiserum No. 2604. 
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Fig. 2. Gel chromatography of neutral (left panel) and acidic (right panel) ileal extracts monitored radioimmunochemically using Ab. 2609 that 
recognize the common C-terminus of gastrin and CCK (upper panel), Ab. 1564 that specifically recognizes CCK (middle panel), and Ab. 3208 that 
binds glycine-extended gastrin and CCK (lower panel). The fractions between the bars were pooled. Five ml ileal neutral extract was freeze-dried 
and redissolved in 1 ml H,O, then applied to a Sephadex G-SO superfine column (10 x 1000 mm) and eluted at 4°C with 0.02 M Verona1 buffer 
(pH 8.4) at a rate of 4 ml/h. 
by reversed-phase chromatography. Extracts concentrated on C-18 
Sep-Pak cartridges were applied to a Vydac (Hesperia, CA, USA) C4 
silica column (250 mm), which was eluted in a CH,CN gradient with 
10 mM NH,, acetate at 5O’C at a rate of 1 ml/min. Fractions of 0.5 ml 
were assayed. The column was calibrated with porcine gastrin-34 in 
sulfated and non-sulfated forms. 
2.5. cRNA probes and oligoDNA primers 
A [32P]UTP-labelled rat CCK cRNA probe was transcribed by T7 
RNA polymerase from cDNA inserted into a pBluescript vector (Strat- 
agene, La Jolla, CA, USA). The CCK cDNA extends from position 163 
to 543 of the rat CCK sequence [15]. The human gastrin cRNA probe 
was transcribed with SP6 RNA polymerase from a 261 base pair (bp) 
Hind111 fragment of the human cDNA [16] subcloned into a pGEM3 
vector (Promega, Madison, WI, USA) [17]. The oligonucleotide probes 
Table 1 
Porcine ileal gastrin and CCK immunoreactivity @mol/g wet weight 
(mean and range (n = 6)) 
Gas&in CCK 
Prohormone 0.3 (0.02-0.4) 7.6 (4.5-12.0) 
Glycine-extended intermediates 1.1 (0.41.4) 13.5 (8.7-24.3) 
Carboxyamidated peptides 1.1 (0.7-1.4) 24.8 (10.2-35.8) 
correspond to the nucleotides 10-30 (sense) and nucleotides 374394 
(antisense) of the porcine gastrin gene [18]. For cloning purposes 
BamHI and EcoRI restriction enzyme recognition sites were included 
at the 5’ end of the sense and antisense primers, respectively. 
2.6. RNA extraction and hybridization 
Total cellular RNA was isolated [19] and poly (A)’ RNA was ob- 
tained by oligo(dT)-cellulose chromatography [20]. RNA was frac- 
tioned on 1% agarose-formaldehyde g ls, transferred to Hybond-N 
nylon membrane (Amersham, UK) and UV cross-linked. Hybridiza- 
tion was performed in 50% formamide, 600 mM NaCl, 8 mM Na 
EDTA 120 mM Tris-HCl with 1% SDS and 1% non-fat dried milk 
powder at pH 7.4 for 18 h at 65°C. The filters were washed for 3 x 20 
min in 0.1 SSC (sodium, sodium citrate) with 0.1% SDS at 65°C and 
exposed for 3-14 days at -80°C. 
2.7. Reverse transcription and polymerase chain reaction 
Reverse transcription and polymerase chain reaction were performed 
using a GeneAmp RNA PCR kit according to the manufacturers in- 
structions (Perkin-Elmer Cetus, Norwalk, CT, USA). Briefly, 1 pug of 
total cellular RNA was reverse transcribed using an oligo dT(,,, primer 
followed by 30 cycles of amplification (1 min at 94”C, 1 min at 62”C, 
2 min at 72”C, and finally 7 min at 72’C). The amplified products were 
separated by gel electrophoresis on a 3% Nusieve 3:l agarose gel (FMC 
Bioproducts, Rockland, NY, USA) in 1 x TAE buffer and visualised 
by ethidium bromide staining. For control, the product was cleaved 
with Ban and PvuII restriction enzymes, which yielded the correct sizes 
of the products (data not shown). 
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3. Results 12M 1 2 
3.1. Progastrin and its products 
The ileum contained 0.3 pmol/g of progastrin, 1.1 
pmoYg glycine-extended, and 1.1 pmol/l amidated gas- 
trin (Table 1). The amidated gastrin eluted as non-sul- 
fated gastrin-34 (Fig. 1). The identity of gastrin-34 was 
corroborated by rechromatography after incubation 
with trypsin, using antibodies directed the C- and the 
N-terminus of gastrin-17. Likewise, glycine-extended 
and further C-terminally extended precursors eluted 
after cleavages in one peak corresponding to glycine- 
extended gastrin-17 (data not shown). The lack of sul- 
fation was demonstrated by the similar binding to Ab. 
2604 and 2605 (Fig. l), and further by elution in a posi- 
tion identical to that of non-sulfated porcine gastrin-34 
in three chromatographic systems (Fig. 1). Measure- 
ments of glycine-extended gastrins and progastrins using 
antiserum 5284 before and after arylsulfatase treatment 
yielded identical results (data not shown). Consequently, 
also the gastrin precursors were non-sulfated. 
3.2. ProCCK and its products 
The ileum contained 7.6 pmol/g proCCK, 13.5 pmoYg 
glycine-extended, and 24.8 pmoYg amidated CCK (Table 
1). Chromatography showed that amidated and glycine- 
extended CCK were present in several molecular forms 
of which the predominant were CCK-58 and 8 (Fig. 2). 
The CCK peak near the void volume eluted after cleav- 
age with trypsin and carboxypeptidase B, in two peaks 
corresponding to glycine-extended and amidated CCK- 
8. Chromatography monitored by the assay specific for 
sulfated CCK showed that ileal CCK was completely 
sulfated (Fig. 3). 
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Fig. 3. Anion-exchange of 5 ml of neutral ilial extract was loaded on 
a DEAE-32 cellulose (10 x 150 mm) and eluted at 20°C with NH,HC09 
(33 ml/h) a continuous gradient as shown in the figure (- - - -). Frac- 
tions of 2.8 ml were monitored radioimmunochemically using Ab. 2609. 
403 bp 
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Fig. 4. Left panel: one pg of total RNA was reverse transcribed and 
amplified using a polymerase chain reaction with primers for porcine 
gastrin. 20 pug of sample was loaded and electrophoresed at 40 V for 
6 h. Lane 1, ileal extract; lane 2, antral extract, and lane 3, 1 kb DNA 
ladder (GibcolBRL). Right panel: Northern analysis of CCK mRNA 
in extract of porcine ileum. Total RNA: lane 1, 5 pug from duodenum; 
lane 2, 23 pug from ileum. 
3.4. Gastrin and CCK mRNA 
Northern analysis of RNA from the duodenal and 
ileal mucosa demonstrated aspecific 0.7 kb CCK mRNA 
in both tissues (Fig. 4, left panel), whereas the gastrin 
mRNA in the ileum was below the detection limit. Re- 
verse transcription PCR revealed, however, gastrin 
mRNA in the ileum (Fig. 4, right panel) in low concen- 
trations. 
4. Discussion 
The present study has shown that both CCK and gas- 
trin genes are expressed in the distal ileum. Ileal progas- 
trin is processed in a unique tissue-specific manner, 
whereas ileal proCCK is processed as in the proximal 
small intestine. We did not find other peptides having 
the characteristic C-terminus, Trp-Met-Asp-Phe-NH,. 
Therefore, the results suggest hat TG-cells produce a 
peptide with a C-terminus resembling, but still different 
from that of CCK and gastrin. 
Expression of the CCK gene was expected, since the 
distal ileum contains a few I-cells [4,5]. Accordingly, ileal 
proCCK processing as in proximal parts of the small 
intestine [21] was to be expected. More surprising is gas- 
trin in the distal ileum. Previous studies have confined 
gastrin synthesis in the digestive tract to G-cells in the 
antroduodenal mucosa and - sporadically - in the proxi- 
mal jejunum [22,23]. Antral G-cells synthesize five bioac- 
tive gastrins, of which gastrin-6 is completely sulfated, 
whereas gastrin-17, -34, and -71 are partly sulfated (for 
review, see [l]l). Consequently, the ileal processing to a 
single carboxyamidated form, non-sulfated gastrin-34, is 
unique. It bears some resemblance to the processing in 
pituitary corticotrophs, where non-sulfated gastrin-34 
L., Friis-Hansen. J.E RehfeldlFEBS Letters 343 (1994) 115-119 
constitutes a majority of the ~-amidated gastrin [24]. But 
corticotrophs contain in addition gastrin-71, and besides 
less than 2% of the pituitary progastrin mature to (r- 
amidated gas&ins [25]. It is noteworthy that the prote- 
olytic processing to gastrin-34 requires cleavage only at 
two -Arg-Arg- sites, whereas mono-Arg and the -Lys- 
Lys- site N-terminal to the gas&in-17 sequence are un- 
processed. Thus, ileal gastrin producing cells express a 
smaller number of processing enzymes than G-cells. Ac- 
cordingly, our results argue that complete progastrin 
processing requires at least three different endopro- 
teases, one for -Arg-Arg- cleavage, one for -Lys-Lys- 
cleavage, and one for mono-Arg cleavages. 
The major question af this study was whether the gas- 
trin or CCK in the ileum is compatible with the abundant 
TG-cells. Comparison with other gastrin or CCK pro- 
ducing endocrine tissues makes it unlikely that the im- 
munoreactivity of ileal TG-cells can be accounted for by 
the low concentrations of CCK and gastrin. On the con- 
trary, the ileal CCK is easily explained by the small ileal 
population of I-cells, and the ileal concentration of gas- 
trin-34 is anyway too low to be identified by i~unocy- 
tochemistry. 
An explanation for the lack of TG-cell products in this 
study might be poor efficiency of the extraction tech- 
niques. However, since all known fragments of progas- 
trin and proCCK are well extracted from other mucosal 
tissue by the general techniques used in this study [26], 
we find such explanation unlikely. Rather, our results 
suggest that the peptide in the secretory granules of the 
TG-cells are neither proCCK nor progastrin products. 
The results also exclude the possibility that TG-cells ex- 
press a proper third member of the gas&in-CCK family. 
In order to qualify as such, an intact C-terminal -Trp- 
jet-Asp-Phe-NH~ sequence is required. If ileal extracts 
contained peptides with such C-terminus (but otherwise 
different from gas&in and CCK) they would inevitably 
have been measured by antiserum No. 2609. The results 
therefore indicate that TG-cells synthesize a peptide, 
which has a limited similarity with gastrin or CCK. Such 
peptide is not recognized in the highly specific radi- 
oimmunoassays, although they may bind antibodies by 
the less specific and competitive i~unocytochemi~l 
techniques. Recent examples of such less specific staining 
are the 1~aDF~ide peptide in snail neurons [27], and 
the CGRP-containing neurons in the spinal cord [2S]. So 
far, however, CGRP in the gut has been found only in 
neurons [29,30]. Consequently, the molecular nature of 
the TG-cell product still remains to be identified. Simi- 
larity with invertebrate 1~naDFa~des 1271 might be a 
starting point for further search. 
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